암치료

종양학의 용도 변경 약물: 후보 선택에서 임상 채택까지

unicircle 2021. 8. 22. 17:05

 

Repurposing drugs in oncology: From candidate selection to clinical adoption

https://www.sciencedirect.com/science/article/pii/S1044579X20300110

 

Repurposing drugs in oncology: From candidate selection to clinical adoption

Drug repurposing is a strategy that aims to develop novel cancer treatments through the reuse of existing medicines developed in other disease areas. …

www.sciencedirect.com

Table 1. Osteosarcoma repurposing candidates and mechanisms of action.

Mechanism of ActionDrug (main indication)Type of evidenceCell differentiationCytotoxicity & potentiation of chemotherapyStem cells cytotoxictyImmunomodulationEpigenetic modificationsCell-cell interaction

Calcitriol (vitamin D deficiency) Animal model
Simvastatin (hypercholesterolemia) Animal model
Glucocorticoids (inflammation) Animal model
Caffeine (infant apnea) Human trial / Animal model
Esomeprazole (peptic ulcer) Human trial / Animal model
Verapamil (hypertension) Case reports / In vitro
Piroxicam (osteoarthritis) Canine trials / Animal model
Metformin (type 2 diabetes) Animal model
Disulfiram (alcohol dependency) In vitro
Sirolimus (prevention organ rejection) Human trial / Animal model
Valproic acid (epilepsy) Animal model
Aspirin (CVD prevention) Animal model
Heparin (VTE) Animal model
Warfarin (embolisation) Human trial / Animal model
Plerixafor (stem cell mobilization) Animal model

CVD – cardiovascular diseases; VTE – venous thromboembolism.